Janssen-Cilag Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Janssen-Cilag Ltd.
RECRUITINGNCT06285318
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell...
The purpose of this study is to describe the use of teclistamab/talquetamab in the treatment of patients with RRMM outside of clinical trials.
Sponsor: Janssen-Cilag Ltd.Enrolling: 90020 locations
Relapsed/Refractory Multiple Myeloma (RRMM)
RECRUITINGNCT07242248
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's...
The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and what are the...
Sponsor: Janssen-Cilag Ltd.Enrolling: 2201 location
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
RECRUITINGPhase 3NCT06408935
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
The purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic...
Sponsor: Janssen-Cilag Ltd.Enrolling: 11220 locations
Crohn's Disease